Pelitinib (EKB-569)
Catalog No. A10706
Pelitinib (EKB-569)是一种有效的,不可逆EGFR抑制剂,IC50为38.5 nM
- Shi P, .et al. The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAIL-Induced Apoptosis in NSCLC Cells with Activating EGFR Mutations, Transl Oncol, 2019, Mar 8;12(5):705-713 PMID: 30856555
Catalog Num | A10706 |
---|---|
M. Wt | 467.9 |
Formula | C24H23ClFN5O2 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 257933-82-7 |
Synonyms | WAY-EKB 569 |
SMILES | CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)/C=C/CN(C)C |
Pelitinib (EKB-569)是一种有效的,不可逆EGFR抑制剂,IC50为38.5 nM
Targets
Target | Value |
---|---|
EGFR | IC50: 38.5nM |
Src | IC50: 282nM |
MEK/ERK | IC50: 800nM |
ErbB2 | IC50: 1.255μM |
Raf | IC50: 3.353μM |
c-Met | IC50: 4.1μM |
CDK4 | IC50: >20μM |
In vitro | DMSO | 12 mg/mL (25.64 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.37 mL | 106.86 mL | 213.72 mL |
0.5 mM | 4.27 mL | 21.37 mL | 42.74 mL |
1 mM | 2.14 mL | 10.69 mL | 21.37 mL |
5 mM | 0.43 mL | 2.14 mL | 4.27 mL |
*The above data is based on the productmolecular weight 467.9 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.